Pazopanib Hcl
Brand name: Votrient
Rank #483 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$14.5M
Total Cost
1,156
Total Claims
$14.5M
Total Cost
81
Prescribers
$13K
Cost per Claim
0
Beneficiaries
1,159
30-Day Fills
$179K
Avg Cost/Provider
14
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$14.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $14.5M total
🔎 Data Overview
At $12,513 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $178,582 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Pazopanib Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Mia Weiss | Medical Oncology | Saint Louis, MO | 37 | $621K |
| 2 | Mark Agulnik | Medical Oncology | Los Angeles, CA | 33 | $503K |
| 3 | Brian Boulmay | Hematology-Oncology | New Orleans, LA | 19 | $339K |
| 4 | Harshraj Leuva | Hematology | Bellevue, NE | 23 | $317K |
| 5 | Sharon Levandowski | Hematology-Oncology | Midland, MI | 30 | $302K |
| 6 | Kamlesh Sankhala | Hematology-Oncology | Beverly Hills, CA | 20 | $300K |
| 7 | Morgan Mount | Nurse Practitioner | Miami, FL | 16 | $288K |
| 8 | Lowell Anthony | Medical Oncology | Lexington, KY | 19 | $281K |
| 9 | Derek Shek | Medical Oncology | San Leandro, CA | 20 | $277K |
| 10 | Xinhua Zhu | Medical Oncology | New Hyde Park, NY | 18 | $272K |
| 11 | Arun Singh | Hematology-Oncology | Santa Monica, CA | 16 | $257K |
| 12 | Maria Zarzour | Medical Oncology | Houston, TX | 14 | $243K |
| 13 | Lawrence Fong | Hematology-Oncology | Seattle, WA | 12 | $237K |
| 14 | Mikhail Grinberg | Hematology-Oncology | Brooklyn, NY | 12 | $228K |
| 15 | Lauren Zatarain | Hematology-Oncology | Baton Rouge, LA | 16 | $228K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 480 | Mometasone Furoate (Mometasone Furoate) | $14.7M | 266,966 |
| 481 | Lorlatinib (Lorbrena) | $14.7M | 720 |
| 482 | Rasagiline Mesylate (Rasagiline Mesylate) | $14.5M | 47,985 |
| 483 | Pazopanib Hcl (Votrient) | $14.5M | 1,156 |
| 484 | Exemestane (Exemestane) | $14.5M | 66,285 |
| 485 | Dihydroergotamine Mesylate (Dihydroergotamine Mesylate) | $14.4M | 6,855 |
| 486 | Clotrimazole/Betamethasone Dip (Clotrimazole-Betamethasone) | $14.4M | 503,015 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology